产品名称 | NebuSelect™ Recombinant Cynomolgus CLEC12A/MICL/CLL-1, His-tag |
---|---|
目录号 | NBL-242811 |
别名 | CLEC12A/MICL/CLL-1; MICL; CLL-1; CLEC12A; CLL1; DCAL2; DCAL-2; CD371; CD303; CLECSF11; CLECSF7; DLEC; HECL; PRO34150; DCAL-2 |
外观 | see COA |
分子量 | His32-Ala232 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | A0A2K5WXQ6 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242811-100ug | 100ug | Inquire | Inquire | |
NBL-242811-1mg | 1mg | Inquire | Inquire | |
NBL-242811-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Cynomolgus CLEC12A/MICL/CLL-1, His-tag
Catalog#:
NBL-242811
Description:
NebuSelect™ Recombinant Cynomolgus CLEC12A/MICL/CLL-1, His-tag(Cat#NBL-242811) is expressed in HEK293 with His tag at the N-Terminus.It contains His32-Ala232.
Species:
Cynomolgus
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 24.6 kDa. Due to glycosylation, the protein migrates to 38-50 kDa based on Bis-Tris PAGE result.
Target Name:
CLEC12A/MICL/CLL-1; MICL; CLL-1; CLEC12A; CLL1; DCAL2; DCAL-2; CD371; CD303; CLECSF11; CLECSF7; DLEC; HECL; PRO34150; DCAL-2
Target Information:
CLEC12A has recently been identified as an antigen, expressed on leukemic stem cells and leukemic blasts. Given the fact that this expression profile seems stable throughout diagnosis, treatment and relapse on leukemic blasts and leukemic stem cells, CLEC12A can be considered a highly potent and reliable marker for the detection of measurable residual disease and therefore applicable for risk stratification and prognostication in AML.
Amino Acid Sequence:
His32-Ala232
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.